Use of low-dose clinical pharmacodynamic and pharmacokinetic data to establish an occupational exposure limit for dapagliflozin, a potent inhibitor of the renal sodium glucose co-transporter 2
| Autor: | Gould, Janet C., Kasichayanula, Sreeneeranj, Shepperly, David C., Boulton, David W. |
|---|---|
| Zdroj: | In Regulatory Toxicology and Pharmacology October 2013 67(1):89-97 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect